Angioedema in the ED
This enduring educational program is designed for Practitioners in the Emergency Medicine Setting who manage angioedema including Hereditary Angioedema and other non-histamine related swelling episodes.
The goal of Angioedema in the Emergency Medicine Setting: Optimizing Management for Every Patient will be to provide clinical insight for the diagnosis of angioedema in the Emergency Department and its varied etiology.
- Differentiate between the clinical presentations of angioedema and generalized edema
- Identify the two primary pathways that are responsible for angioedema episodes that require care in the Emergency Department
- Develop a proactive approach to diagnosing angioedema that includes Hereditary Angioedema
- Initiate appropriate therapy based upon the most likely cause of angioedema i.e. histamine mediated versus bradykinin mediated
- Collaborate with patients and their HAE physician to develop prophylactic and acute care strategies to manage their angioedema attacks
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of CMEsolutions and US Hereditary Angioedema Association. The CMEsolutions is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The CMEsolutions designates this enduring activity for a maximum of 1.75 AMA PRA Category 1 Credits.™ Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This continuing nursing education activity was approved by the Western Multi-State Division, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. 1.75 contact hours provided.
Western Multi-State Division and ANCC Commission on Accreditation do not approve or endorse any commercial products displayed.
The CMEsolutions is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program is approved for 1.75 contact hours (0.175 CEUs). ACPE Program Number: 0274-9999-16-015-H04-P
Faculty and Disclosures
CMEsolutions requires everyone in a position to control the content of this activity to disclose any relevant financial conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by CMEsolutions for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
Marc A. Riedl, MD, MS
Professor of Medicine UCSD Allergy and Immunology,
Department of Medicine Clinical Director, US HAEA Angioedema Center at UCSD
Dr. Riedl has disclosed the following relevant financial interests:
Research Support: Dyax/Shire, CSL Behring, Ionis Pharming
Jesse Pines, MD, MBA, MSCE
Director of the Center for Healthcare Innovation & Policy Research at The George Washington University
Professor of Emergency Medicine and Health Policy
Dr. Pines has disclosed the following relevant financial interests: Research Support: Point-of-Care
No member of CMEsolutions or US Hereditary Angioedema Association has any relevant financial relationships to disclose.
There are registration fees as explained on the website: www.haeedu.com
- Study CME Information Page
- View Video
- Complete evaluation, credit request form, and your credit statement will be sent within two weeks. Pharmacy Credits will be submitted once your attendance, NABP# and birthdate (MM/DD) have been verified.
Angioedema in the Emergency Medicine Setting: Optimizing Management for Every Patient may contain discussion of unlabeled and/or investigational uses of agents not approved by the FDA. Please consult the prescribing information for each product.
There will be no commercial support provided for this activity.
CMEsolutions Privacy and Confidentiality Policy: www.online-med-edu.com/privacypolicy.pdf
CMEsolutions can be contacted at email@example.com.
Initial Release Date: 10/11/2016 End Date: 10/11/2018
Windows 8 or higher
Google Chrome or Firefox
Adobe Acrobat Reader
Mac OS 10.2.8
Adobe Acrobat Reader